Breast Cancer

A depression diagnosis before and after a breast cancer diagnosis appeared associated with worse survival outcomes, according to study results published in Cancer.

Whole-exome sequencing identified carriers of predisposition genes for hereditary breast and ovarian cancer or Lynch syndrome who, under current guidelines, would not have qualified for genetic testing, according to study results.

Black and Asian women with early-stage, hormone-receptor positive, HER2-negative, node-negative breast cancer appeared about twice as likely as their white counterparts to experience locoregional recurrence.

In the 10 years after radiotherapy for breast cancer, the rate of CV mortality remained second to cancer mortality; however, patients had increased incidence of HF and arrhythmias compared with matched controls, researchers reported.

Cancers diagnosed during pregnancy or 1 year post-partum had greater overall 5-year mortality compared with those not diagnosed near pregnancy, but risks were not the same for all cancer sites, researchers reported in JAMA Oncology.

A therapy commonly used for gender affirmation in transgender men potentially could have a role in the development of therapies for ER-positive breast cancer, according to a study published in Cell Genomics.

The Healio Editors compiled a list of recent news from the Society of Gynecologic Oncology Annual Meeting held from March 25-28, 2023.

Racial and ethnic subtype-specific differences in pathologic complete response rates after neoadjuvant chemotherapy for breast cancer may partially account for worse survival rates for Black women, according to study data.

The addition of ribociclib to adjuvant endocrine therapy significantly reduced the risk for disease recurrence among patients with hormone receptor-positive, HER2-negative early breast cancer, according to the agent’s manufacturer.

Compared with other people with breast cancer, those with a preexisting severe mental illness were less likely to receive appropriate treatment and more likely to experience delays in receiving treatment, findings in Psycho-Oncology showed.